Skip to main content
SpringerLink
Log in
Book cover

Drug-Induced Lung Injury pp 103–112Cite as

Differential Diagnoses of DLI: What Are the Differential Diagnoses of DLI?

  • Chapter
  • First Online:

  • 661 Accesses

Abstract

Lung injury can be diagnosed as drug induced when it develops during the time span of drug intake, when it is a possible side effect of the drug, and after excluding other causes. Even if a new lung injury appears immediately after drug administration, it does not necessarily mean that it is drug induced. Some considerations could be pneumonia caused by an opportunistic infection, exacerbation of underlying disease, or other unrelated diseases. The differential diagnoses of drug-induced lung injury are described in this chapter.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Kubo K, Azuma A, Kanazawa M, Kameda H, Kusumoto M, Genma A, Saijo Y, Sakai F, Sugiyama Y, Tatsumi K, Dohi M, Tokuda H, Hashimoto S, Hattori N, Hanaoka M, Fukuda Y, Japanese Respiratory Society Committee for formulation of Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir Invest. 2013;51(4):260–77.

    Google Scholar 

  2. Yokoyama A. Approach to the diagnosis of drug-induced lung diseases. Nihon Naika Gakkai Zasshi. 2007;96(6):1097–103.

    Article  CAS  PubMed  Google Scholar 

  3. Japanese Respiratory Society Committee for formulation of the guide for the Biological agents and respiratory diseases: Guide for the medical treatment. Biological agents and respiratory diseases: Guide for the medical treatment. 2014. http://www.jrs.or.jp/modules/guidelines/index.php?content_id=69.

  4. Hirata S, Hattori N, Kumagai K, Haruta Y, Yokoyama A, Kohno N. Lymphocyte transformation test is not helpful for the diagnosis of methotrexate-induced pneumonitis in patients with rheumatoid arthritis. Clin Chim Acta. 2009;407(1–2):25–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132(5):1652–8.

    Article  PubMed  Google Scholar 

  6. Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, Fujii Y, Mitsudomi T, Yoshimura M, Maniwa T, Suzuki K, Kataoka K, Sugiyama Y, Kondo T, Date H, Japanese Association for Chest Surgery. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147(5):1604–11.

    Article  PubMed  Google Scholar 

  7. Azuma A, Kudo S. Drug-induced pneumonia and Japanese. Nihon Naika Gakkai Zasshi. 2007;96(6):1077–82.

    Article  PubMed  Google Scholar 

  8. Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y, Tsuya A, Kaira K, Murakami H, Takahashi T, Endo M, Yamamoto N. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol. 2011;6(7):1242–6.

    Article  PubMed  Google Scholar 

  9. Niho S, Goto K, Yoh K, Kim YH, Ohmatsu H, Kubota K, Saijo N, Nishiwaki Y. Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs. Jpn J Clin Oncol. 2006;36(5):269–73.

    Article  PubMed  Google Scholar 

  10. Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J. 2000;15(2):373–81.

    Article  CAS  PubMed  Google Scholar 

  11. Johkoh T, Müller NL, Akira M, Ichikado K, Suga M, Ando M, Yoshinaga T, Kiyama T, Mihara N, Honda O, Tomiyama N, Nakamura H. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology. 2000;216(3):773–80.

    Article  CAS  PubMed  Google Scholar 

  12. Poletti V, Salvucci M, Zanchini R, Molinari AL, Zuffa E, Poletti G, Zaccaria A. The lung as a target organ in patients with hematologic disorders. Haematologica. 2000;85(8):855–64.

    CAS  PubMed  Google Scholar 

  13. Kameda T, Dobashi H. Rheumatoid arthritis and malignancy. Nihon Rinsho. 2016;74(6):1017–21.

    PubMed  Google Scholar 

  14. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther. 2009;7(10):1201–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Couturier MR, Graf EH, Griffin AT. Urine antigen tests for the diagnosis of respiratory infections: legionellosis, histoplasmosis, pneumococcal pneumonia. Clin Lab Med. 2014;34(2):219–36.

    Article  PubMed  Google Scholar 

  16. Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50(1):7–15.

    Google Scholar 

  17. Kopterides P, Tsangaris I. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients. Minerva Anestesiol. 2012;78(7):823–35.

    CAS  PubMed  Google Scholar 

  18. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med. 2004;25(1):25–35.

    Article  PubMed  Google Scholar 

  19. Kondo K, Inoue Y, Hamada H, Yokoyama A, Kohno N, Hiwada K. Acetaminophen-induced eosinophilic pneumonia. Chest. 1993;104(1):291–2.

    Article  CAS  PubMed  Google Scholar 

  20. Ohnishi H, Yokoyama A, Yasuhara Y, Watanabe A, Naka T, Hamada H, Abe M, Nishimura K, Higaki J, Ikezoe J, Kohno N. Circulating KL-6 levels in patients with drug-induced pneumonitis. Thorax. 2003;58(10):872–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Respiratory Medicine, Kochi Medical School Hospital, Kochi University, 185-1 Kohasu, Oko-cho, Nankoku-shi, Kochi, 783-8505, Japan

    Akihito Yokoyama

Authors
  1. Akihito Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akihito Yokoyama .

Editor information

Editors and Affiliations

  1. First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

    Masayuki Hanaoka

  2. Ibaraki Medical Center, Tokyo Medical University, Ibaraki, Japan

    Hiroyuki Nakamura

  3. Ibaraki Medical Center, Tokyo Medical University, Ibaraki, Japan

    Kazutetsu Aoshiba

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Yokoyama, A. (2018). Differential Diagnoses of DLI: What Are the Differential Diagnoses of DLI?. In: Hanaoka, M., Nakamura, H., Aoshiba, K. (eds) Drug-Induced Lung Injury. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-10-4466-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4466-3_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4465-6

  • Online ISBN: 978-981-10-4466-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation